A significant advance in cancer study is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This crucial tumor suppressor protein is frequently disabled in many types of malignancies, leading https://top100bookmark.com/story22127259/mini-antibodies-reactivate-p53-a-potential-hope-for-tumor-therapy